Part 2 of Schedule 1 to the Principal Act is amended as follows:
by inserting after item 10 the following item:
by omitting items 29B and 29C and substituting the following items:
| 1-benzofuran-5-ylpropan-2-amine (otherwise known as 5-(2-aminopropyl)benzofuran or 5-APB) | 25g or 20 units |
| 1-benzofuran-6-ylpropan-2-amine (otherwise known as 6-(2-aminopropyl)benzofuran or 6-APB) | 25g or 20 units |
by omitting items 85A and 85B and substituting the following items:
| 1-(2,3-dihydro-1-benzofuran-5-yl)propan-2-amine (otherwise known as 5-(2-aminopropyl)-2,3-dihydrobenzofuran or 5-APDB) | 25g or 20 units |
| 1-(2,3-dihydro-1-benzofuran-6-yl)propan-2-amine (otherwise known as 6-(2-aminopropyl)-2,3-dihydrobenzofuran or 6-APDB) | 25g or 20 units |
by inserting after item 99 the following item:
| 2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (otherwise known as 25H-NBOMe) | |
by inserting after item 106 the following item:
| 1-(1,2-diphenylethyl)piperidine (otherwise known as diphenidine) | |
by inserting after item 120 the following item:
by inserting after item 162 the following item:
by omitting item 239A and substituting the following item:
| 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (otherwise known as α-pyrrolidiniopentiophenone or α-PVP) | 25 grams (or 20 units) |
The amendments effected by this clause have been incorporated into the authorised version of the Misuse of Drugs Act 2001.